Latest filing published 14 Jul 2022 for bluebird bio, Inc., €6,700.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Anne-Virginie Eggimann: trading record in brief
Anne-Virginie Eggimann (senior executive) discloses dealings in bluebird bio, Inc. to SEC (Form 4). Between 1 February 2022 and 12 July 2022, the trades on record add up to 2 filings.
The open-market record consists of 1 sale worth €6,700, with no purchase. Besides market trades, the filings include 1 share grant.
The newest entry dates from 14 July 2022: an open-market sale of €6,700, in bluebird bio, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Anne-Virginie Eggimann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,358 shares@ US$4.95100.0% of flowCommon StockSEC:0001562180-22-005668:0
- 17,000 shares0Common StockSEC:0001562180-22-001087:0
2 of 2 declarations
